title: Preliminary evaluation of the WV Prescription Drug Abuse Ouitline.
abstract: OBJECTIVE
  To evaluate the effectiveness of the West Virginia Prescription Drug Abuse Quitline (WVPDAQ).
  
  
  METHODS
  Descriptive data and inferential analyses are provided for the period of operations from 9/11/2008 to 3/1/2010. Chi-square tests for Independence compared differences between callers completing at least one follow-up survey against callers completing only the baseline intake survey were observed. A Wilcoxon signed rank sum test tested differences between the scores of intake callers and follow-up callers at the one-week (n = 177) and one-month (n = 89) intervals.
  
  
  RESULTS
  A total of 1,056 calls were received, including 670 intakes, 177 1st follow-ups, 89 2nd follow-ups, and 36 3rd follow ups, and 84 caller satisfaction surveys. Chi-square analyses determined that callers who only completed the intake survey tended to have initiated drug use at a younger age (< or = 39 years of age, chi2 = 7.63, p = .02). Longitudinal findings indicated significant self-reported declines in daily drug use (p < .0001), increased intentions to quit in the next 30 days (p < .0001), and declines in requesting a referral for treatment (p < .0001) at the one-month follow-up. Finally, approximately 19% (n = 17) of callers reported obtaining a counseling/ treatment appointment as a result of calling the WVPDAQ at the one-month follow up.
  
  
  CONCLUSIONS
  Preliminary results suggest the WVPDAQ has established itself as a meaningful resource to combat prescription drug abuse in West Virginia. Sustainable funding and greater integration of the WVPDAQ into existing and developing treatment infrastructure could provide more affordable options for the state of West Virginia and its citizens.
authors.affiliation: Department of Community Medicine, West Virginia University Morgantown, WV, USA.
authors.forename: Keith J
authors.initials: KJ
authors.lastname: Zullig
authors.forename: Laura
authors.initials: L
authors.lastname: Lander
authors.forename: Rebecca J
authors.initials: RJ
authors.lastname: White
authors.forename: Carl
authors.initials: C
authors.lastname: Sullivan
authors.forename: Clara
authors.initials: C
authors.lastname: Shockley
authors.forename: Lili
authors.initials: L
authors.lastname: Dong
authors.forename: Robert P
authors.initials: RP
authors.lastname: Pack
authors.forename: Tara Surber
authors.initials: TS
authors.lastname: Fedis
mesh_terms: D000328:Adult; D005260:Female; D015277:Hotlines / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D008875:Middle Aged; D010353:Patient Education as Topic; D017060:Patient Satisfaction; D055553:Prescription Drugs; D015397:Program Evaluation; D012017:Referral and Consultation; D019966:Substance-Related Disorders / Q000534:rehabilitation / Q000628:therapy*; D014903:West Virginia; D055815:Young Adult
chemical_list: D055553:Prescription Drugs